Skinfold fat measurement and survival in certain digestive cancers
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This study looks at whether a simple measurement of fat under the skin (taken at the back of the upper arm) relates to how long people live. It includes adults newly diagnosed with pancreatic, bile duct, or gallbladder cancer who are starting treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been newly diagnosed with pancreatic, bile duct, or gallbladder cancer.
- You are currently receiving treatment such as surgery, chemotherapy, or palliative (comfort-focused) care.
- You do not have another cancer (a different malignant disease).
- You do not have an intestinal condition that causes trouble absorbing food.
- You do not have a psychiatric condition such as an eating disorder (bulimia or anorexia).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies a blood test that looks for tiny traces of cancer-related DNA (called ctDNA) in people with pancreatic cancer that can be removed with surgery. The goal is to see whether this test can better predict how the cancer behaves and guide treatment decisions around surgery.
This trial uses a simple blood test to track how well bile duct cancer responds to treatment and to predict outcomes. It may help doctors make better decisions about surgery and other therapies.
This study uses a blood test to look at how your immune system responds, which may help tell if chronic pancreatitis could turn into pancreatic cancer. It aims to find better ways to monitor people with chronic pancreatitis and catch cancer earlier.
This study looks at how well people do after surgery for liver, bile duct, or pancreas cancer, using a body composition test (the “inBody” test). It may help doctors understand which body changes after surgery are linked to better or worse recovery.
This trial looks at how well patient-recorded measurements can be used during cancer care around the time of curative-intent surgery or chemotherapy before surgery. It may help improve monitoring and decision-making during treatment.
This study looks at blood markers and gut bacteria to better understand the risk of pancreatic cancer in people with chronic pancreatitis (long-term pancreas inflammation). It may help detect cancer earlier or guide prevention.
Hear when a new Pancreas Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.